Skip to main content

and
  1. Article

    Open Access

    The prevalence and outcomes of frail older adults in clinical trials in multiple myeloma: A systematic review

    Multiple myeloma (MM) is an incurable blood cancer that primarily affects older adults. Several frailty tools have been developed to address the heterogeneity of aging in this population. Uptake of these measu...

    Hira Mian, Arleigh McCurdy, Smith Giri, Shakira Grant in Blood Cancer Journal (2023)

  2. Article

    Open Access

    Ixazomib-based induction regimens plus ixazomib maintenance in transplant-ineligible, newly diagnosed multiple myeloma: the phase II, multi-arm, randomized UNITO-EMN10 trial

    Roberto Mina, Antonietta Pia Falcone, Sara Bringhen in Blood Cancer Journal (2021)

  3. Article

    Open Access

    Octogenarian newly diagnosed multiple myeloma patients without geriatric impairments: the role of age >80 in the IMWG frailty score

    Mattia D’Agostino, Alessandra Larocca, Massimo Offidani in Blood Cancer Journal (2021)